Natin nɔ de we de mek yu fil pen pas fɔ wach pɔsin we yu lɛk, ilɛksɛf na yu yon mama ɔ papa, de fɔgɛt tin smɔl smɔl. Fɔs, yu kin fɔgɛt smɔl smɔl tin dɛn lɛk usay yu put yu ki ɔ yu tu glas. Dɔn i kin at fɔ tɔk to pipul dɛn, disayd fɔ du sɔntin, ɛn ivin du di wok dɛn we wi kin du ɛvride. Dis na de harsh rial tin wae de kam wit Alzheimer’s Disease. Na nɔmal tin fɔ fil se yu nɔ ebul fɔ du natin ɛn yu at pwɛl pan tɛm lɛk dis. Bɔt, nɔ wɔri. Lɛ wi tɔk bɔt dis kɔndishɔn ditayli.
Yu tink se dɛn go rili ebul fɔ mɛn di sik we dɛn kɔl Alzaima kpatakpata?
Di rayt ansa to dis kwɛstyɔn na nɔ . Na dis tɛm, wans Alzaima sik dɔn bigin, dat min se wans sɔm sayn dɛm lɛk wae yu nɔr de mɛmba, wae yu nɔr kin ebul fɔ lan, ɛn wae yu kin gɛt prɔblɛm wit yu fɔ disayd, nɔr tritmɛnt nɔr de na di wɔl wae go ebul fɔ stɔp am ɔltogɛda ɔr kin rivɛns am.
Bɔt di stori nɔ de dɔn de. Di tin wae impɔtant pas ɔl na dat, mɛrɛsin dɛn de wae kin ɛp fɔ pul di sik, slo fɔ mek di sik nɔr de go bifo, ɛn ɛp fɔ mek di bren wok fayn fayn wan fɔ lɔng tɛm. Dis na di rizin we mek i rili impɔtant fɔ go to dɔktɔ fɔ advays.
Aw yu kin pik di bɛst tritmɛnt fɔ di pɔsin we yu lɛk?
Dis na disizhɔn we yu dɔktɔ go disayd. I go tink bɔt bɔku tin dɛn we i de disayd fɔ du dis. Fɔ tɔk am simpul wan, no wan saiz tritmɛnt nɔ de. Dɛn kin mek wan tritmɛnt plan we spɛshal fɔ yu pɔsin.
Di dɔktɔ kin pe atɛnshɔn mɔ pan dɛn tin ya:
- Di pɔsin in ej, ɔl in wɛlbɔdi, ɛn if dɛn gɛt ɔda mɛrɛsin (fɔ ɛgzampul, dayabitis, ay blɔd prɛshɔn).
- Di stej wae de sik wae de mɛk pɔrsin gɛt Alzaima (we nɔr kin pasmak, wae nɔr kin pasmak, ɔr kin tranga).
- Aw di pɔsin kin telɛ di mɛrɛsin ɔ tritmɛnt we dɛn gi am, ɛn aw i kin afɛkt dɛn layf.
- Di tin dɛn we di pɔsin we sik ɛn di famili we de kia fɔ am want ɛn wetin i tink.
Yu dɔktɔ go tink bɔt ɔl dɛn tin ya ɛn disayd wetin na di tritmɛnt we go fayn fɔ yu.
Us mɛrɛsin dɛn de fɔ mɛn Alzaima sik?
Dɛn kin sheb mɛrɛsin fɔ Alzaima sik to sɔm men kategori dɛm. Sɔm mɛrɛsin dɛn kin tray fɔ pul di bad tin dɛn we kin gɛda na di bren. Ɔda wan dɛn kin ɛp fɔ mek di kemikal mɛsej dɛn we de na di bren chenj fayn fayn wan. Lɛ wi ɔndastand dɛn tin ya klia wan.
| Kategori fɔ drɔgs | Aw i de wok simpul wan | Yuz kes dɛn | Ɛgzampul dɛn ɛn not dɛn |
|---|---|---|---|
| Amyloid Plɛk Ridyusɔ dɛn | I de tray fɔ pul di bad bad protin dɛm we dɛn kɔl amyloid beta plaques we kin gɛda na di bren fɔ di wan dɛn we gɛt Alzaima. | Fɔ di fɔs stej dɛm fɔ di sik. | Eks: (Donanemab), (Lɛkanɛmab) . Dɛn kin agyu bɔt if dɛn mɛrɛsin ya kin mek di bren swel ɔ blɔd. Dɛn nɔ de yuz dɛn tin ya yet na wi kɔntri. |
| Mεdikeshכn dεm we de protεkt asetilkolin (Cholinesterase Inhibitors) . | I de kɔntrol di we aw wan kemikal mɛsenja we dɛn kɔl asɛtilkolin, we impɔtant fɔ mɛmba ɛn lan, de brok na di bren. | Fɔ mild ɛn mɔdaret stej dɛm fɔ di sik. | Fɔ ɛgzampul: Dɔnɛpɛzil (Arisɛpt), Galantamin (Razadin), Rivastigmin (Ɛksɛlɔn) . Sɔm kayn bad bad tin dɛn lɛk we yu bɛlɛ kin at, yu kin vɔmit, yu kin gɛt dayarɛa, ɛn yu taya. Aricept na apruv fɔ ɔl di stej dɛm fɔ di sik. |
| Mεdikeshכn we de kכntrol glutamεyt (NMDA Risεptor Antagonist) . | I de kɔntrol aw wan kemikal we dɛn kɔl glutamate de mek pasmak na di bren fɔ di wan dɛn we gɛt Alzaima. If dis kemikal bɔku pasmak, dat kin ambɔg di bren sɛl dɛn. | Fɔ di mɔdaret ɛn siriɔs stej dɛm fɔ di sik. | Fɔ ɛgzampul: Memantine (Namenda) . Sayd ɛfɛkt lɛk diziz, kɔnstipɛshɔn, ed we de at, kɔnfyushɔn kin apin. Sɔntɛnde dɛn kin gi am togɛda wit drɔgs na di grup we de ɔp. |
| Kɔmbayn Drug we dɛn kin yuz | Dɛn dɔn jɔyn di tu kayn drɔgs dɛn we wi dɔn tɔk bɔt ɛn mek dɛn. | Fɔ mek i izi fɔ di wan dɛn we gɛt mɔdaret ɛn siriɔs sikman dɛn we dɔn ɔlrɛdi de tek di tu mɛrɛsin dɛn wan bay wan. | E.g. Namzaric (na wan kɔmbaynshɔn fɔ Memantine ɛn Donepezil). |
Tritmɛnt fɔ ɔda sayn dɛm
Apat frɔm dɛn men mɛrɛsin ya, dɔktɔ dɛn kin gi mɛrɛsin bak fɔ ɔda prɔblɛm dɛn we kin kam wit Alzaima sik. Fɔ ɛgzampul:
- Pwɛl at
- We pɔsin nɔ ebul fɔ slip
- Agiteshɔn ɛn Agreshɔn
If yu trit dɛn wan ya, dat kin mek layf izi fɔ di pɔsin ɛn fɔ yu as pɔsin we de kia fɔ dɛn.
Wi go ebul fɔ gɛt op fɔ tumara bambay?
Fɔ tru, na yɛs! Sayɛnsman dɛn ɔlsay na di wɔl de wok de ɛn nɛt fɔ fɛn mɛrɛsin fɔ Alzaima sik we go de sote go. Bɔku men gol dɛn de fɔ dis risach:
1. Fɔ fɛn nyu mɛrɛsin: Dɛn de du klinik trial ɔltɛm fɔ fɛn nyu mɛrɛsin wae kin stɔp di sik fɔ go bifo ɔr kin mek pɔrsin mɛmba ɛn ɔda sayn dɛm.
2. Wan Alzaima vaysin: Dɛn de du risach bak fɔ mek wan vaysin we go mek pɔsin nɔ gɛt Alzaima sik tumara bambay.
3. Fɔ no di sik kwik kwik wan: Sayɛnsman dɛn de tray fɔ fɛn we fɔ no di sik kwik kwik wan, bifo di sik sho. If dat apin, dɛn kin bigin fɔ trit am kwik ɛn dɛn kin ebul fɔ kɔntrol di sik.
Di tru tin bɔt supamakit
Bɔku tɛm wi kin tink se vaytamɛn, mɔ vaytamɛn E, Coenzyme Q10, Ginkgo Biloba, ɛn Huperzine A sɔpɔtmɛnt dɛn fayn fɔ dis sik. Bɔt, risach te tide nɔr dɔn pruv bay sayɛns se dɛn tin ya kin rili afɛkt di sik we dɛn kɔl Alzaima. Pan ɔl we dɛn dɔn du risach bak bɔt Omega-3 fat asid, di tin dɛn we dɛn dɔn fɛn difrɛn. So , nɔ gi di pɔsin dɛn tin ya if yu dɔktɔ nɔ advays yu.
Mɛsej we dɛn kin kɛr go na os
- Nɔr mɛrɛsin nɔr de fɔ Alzaima sik yet, bɔt nɔr giv ɔp.
- Di mɛrɛsin dɛn we dɛn de tek naw kin kɔntrol di sik dɛn, mek di sik nɔ go bifo kwik kwik wan, ɛn mek i gɛt gud kwaliti layf fɔ sɔm tɛm.
- Tɔk to yu dɔktɔ ɔltɛm fɔ no us tritmɛnt go fayn fɔ di pɔsin we yu lɛk. Nɔ disayd bay di intanɛt ɔ wetin ɔda pipul dɛn se.
- Nɔ tek ɛni sɔpɔtmɛnt ɔ vaytamɛn we yu dɔktɔ nɔ gri fɔ tek. Dɛn nɔr dɔn pruv se dɛn kin wok fayn ɛn dɛn kin miks wit ɔda mɛrɛsin dɛn bad bad wan.
- Op de fɔ tumara bambay as sayɛnsman dɛn de du risach ɔltɛm ɛn fɛn mɔ tritmɛnt dɛn we go wok fayn.
💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt